Last reviewed · How we verify

sodium bicarbonate Ringer injection

Chinese PLA General Hospital · FDA-approved active Small molecule ✓ Verified May 2026 Quality 0/100

sodium bicarbonate Ringer injection is a Small molecule drug developed by Chinese PLA General Hospital. It is currently FDA-approved.

Sodium bicarbonate Ringer injection is a small molecule solution used in medical settings, including cardiac surgery, and is also used as a priming solution for ECMO circuits. It is available under various names, including baking soda and bicarbonate of soda, and has been studied in clinical trials for its safety and efficacy in various conditions.

At a glance

Generic namesodium bicarbonate Ringer injection
SponsorChinese PLA General Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about sodium bicarbonate Ringer injection

What is sodium bicarbonate Ringer injection?

sodium bicarbonate Ringer injection is a Small molecule drug developed by Chinese PLA General Hospital.

Who makes sodium bicarbonate Ringer injection?

sodium bicarbonate Ringer injection is developed and marketed by Chinese PLA General Hospital (see full Chinese PLA General Hospital pipeline at /company/chinese-pla-general-hospital).

What development phase is sodium bicarbonate Ringer injection in?

sodium bicarbonate Ringer injection is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing